1mxo: Difference between revisions

New page: left|200px<br /><applet load="1mxo" size="450" color="white" frame="true" align="right" spinBox="true" caption="1mxo, resolution 1.83Å" /> '''AmpC beta-lactamase ...
 
No edit summary
Line 1: Line 1:
[[Image:1mxo.jpg|left|200px]]<br /><applet load="1mxo" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1mxo.jpg|left|200px]]<br /><applet load="1mxo" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1mxo, resolution 1.83&Aring;" />
caption="1mxo, resolution 1.83&Aring;" />
'''AmpC beta-lactamase in complex with an m.carboxyphenylglycylboronic acid bearing the cephalothin R1 side chain'''<br />
'''AmpC beta-lactamase in complex with an m.carboxyphenylglycylboronic acid bearing the cephalothin R1 side chain'''<br />


==Overview==
==Overview==
beta-lactamases are the most widespread resistance mechanism to, beta-lactam antibiotics, such as the penicillins and the cephalosporins., In an effort to combat these enzymes, a combination of stereoselective, organic synthesis, enzymology, microbiology, and X-ray crystallography was, used to design and evaluate new carboxyphenyl-glycylboronic acid, transition-state analogue inhibitors of the class C beta-lactamase AmpC., The new compounds improve inhibition by over 2 orders of magnitude, compared to analogous glycylboronic acids, with K(i) values as low as 1, nM. On the basis of the differential binding of different analogues, the, introduced carboxylate alone contributes about 2.1 kcal/mol in affinity., This carboxylate corresponds to the ubiquitous C3(4)' carboxylate of, beta-lactams, and this energy represents the first thermodynamic, measurement of the importance of this group in molecular recognition by, class C beta-lactamases. The structures of AmpC in complex with two of, these inhibitors were determined by X-ray crystallography at 1.72 and 1.83, A resolution. These structures suggest a structural basis for the high, affinity of the new compounds and provide templates for further design., The highest affinity inhibitor was 5 orders of magnitude more selective, for AmpC than for characteristic serine proteases, such as chymotrypsin., This inhibitor reversed the resistance of clinical pathogens to the third, generation cephalosporin ceftazidime; it may serve as a lead compound for, drug discovery to combat bacterial resistance to beta-lactam antibiotics.
beta-lactamases are the most widespread resistance mechanism to beta-lactam antibiotics, such as the penicillins and the cephalosporins. In an effort to combat these enzymes, a combination of stereoselective organic synthesis, enzymology, microbiology, and X-ray crystallography was used to design and evaluate new carboxyphenyl-glycylboronic acid transition-state analogue inhibitors of the class C beta-lactamase AmpC. The new compounds improve inhibition by over 2 orders of magnitude compared to analogous glycylboronic acids, with K(i) values as low as 1 nM. On the basis of the differential binding of different analogues, the introduced carboxylate alone contributes about 2.1 kcal/mol in affinity. This carboxylate corresponds to the ubiquitous C3(4)' carboxylate of beta-lactams, and this energy represents the first thermodynamic measurement of the importance of this group in molecular recognition by class C beta-lactamases. The structures of AmpC in complex with two of these inhibitors were determined by X-ray crystallography at 1.72 and 1.83 A resolution. These structures suggest a structural basis for the high affinity of the new compounds and provide templates for further design. The highest affinity inhibitor was 5 orders of magnitude more selective for AmpC than for characteristic serine proteases, such as chymotrypsin. This inhibitor reversed the resistance of clinical pathogens to the third generation cephalosporin ceftazidime; it may serve as a lead compound for drug discovery to combat bacterial resistance to beta-lactam antibiotics.


==About this Structure==
==About this Structure==
1MXO is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with PO4 and SM2 as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Beta-lactamase Beta-lactamase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.5.2.6 3.5.2.6] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1MXO OCA].  
1MXO is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with <scene name='pdbligand=PO4:'>PO4</scene> and <scene name='pdbligand=SM2:'>SM2</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Beta-lactamase Beta-lactamase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.5.2.6 3.5.2.6] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1MXO OCA].  


==Reference==
==Reference==
Line 16: Line 16:
[[Category: Blazquez, J.]]
[[Category: Blazquez, J.]]
[[Category: Caselli, E.]]
[[Category: Caselli, E.]]
[[Category: Focia, P.J.]]
[[Category: Focia, P J.]]
[[Category: Morandi, F.]]
[[Category: Morandi, F.]]
[[Category: Morandi, S.]]
[[Category: Morandi, S.]]
[[Category: Prati, F.]]
[[Category: Prati, F.]]
[[Category: Shoichet, B.K.]]
[[Category: Shoichet, B K.]]
[[Category: PO4]]
[[Category: PO4]]
[[Category: SM2]]
[[Category: SM2]]
Line 28: Line 28:
[[Category: serine hydrolase]]
[[Category: serine hydrolase]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 21:47:09 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:00:07 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA